Literature DB >> 1587170

Challenging the predictive accuracy of Goodsall's rule for anal fistulas.

W C Cirocco1, J C Reilly.   

Abstract

To examine the predictive accuracy of Goodsall's rule, the records of 216 patients (155 men and 61 women) who underwent surgery for complete submuscular anal fistulas from 1982 to 1989 were retrospectively reviewed. In accordance with Goodsall's rule, 90 percent of 124 patients with an external opening posterior to the transverse anal line had anal fistulas tracking to the midline (87 percent men and 97 percent women). Only 49 percent of the 92 patients with an external opening anterior to the transverse anal line had anal fistulas that tracked in the radial fashion predicted by Goodsall (57 percent men and 31 percent women). Instead, 71 percent of these patients (62 percent men and 90 percent women) had anterior fistulas tracking to the midline. Overall, 81 percent (77 percent men and 93 percent women) of patients had complete submuscular anal fistulas that coursed to the midline (51 percent midline posterior and 30 percent midline anterior). In summary, Goodsall's rule is accurate only when applied to complete submuscular anal fistulas with posterior external anal openings. The rule is inaccurate in describing the course of complete submuscular anal fistulas with an anterior external opening. The men in this group had anal fistulas that defied Goodsall's rule in an unpredictable manner, whereas 90 percent of the women had fistulas tracking to a midline anterior origin.

Entities:  

Mesh:

Year:  1992        PMID: 1587170     DOI: 10.1007/bf02050532

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  13 in total

Review 1.  Evaluation and management of perianal abscess and anal fistula: a consensus statement developed by the Italian Society of Colorectal Surgery (SICCR).

Authors:  A Amato; C Bottini; P De Nardi; P Giamundo; A Lauretta; A Realis Luc; G Tegon; R J Nicholls
Journal:  Tech Coloproctol       Date:  2015-09-16       Impact factor: 3.781

2.  David Henry Goodsall: reassessment of the rule.

Authors:  A P Zbar
Journal:  Tech Coloproctol       Date:  2009-07-21       Impact factor: 3.781

3.  It is time to retire Goodsall's Rule: the Midline Rule is a more accurate predictor of the true and natural course of anal fistulas.

Authors:  W C Cirocco; J C Reilly
Journal:  Tech Coloproctol       Date:  2020-02-27       Impact factor: 3.781

4.  Evaluation and management of perianal abscess and anal fistula: SICCR position statement.

Authors:  A Amato; C Bottini; P De Nardi; P Giamundo; A Lauretta; A Realis Luc; V Piloni
Journal:  Tech Coloproctol       Date:  2020-01-23       Impact factor: 3.781

5.  Anal fistula: intraoperative difficulties and unexpected findings.

Authors:  Ahmed A Abou-Zeid
Journal:  World J Gastroenterol       Date:  2011-07-28       Impact factor: 5.742

6.  For many high anal fistulas, lay open is still a good option.

Authors:  G K Atkin; J Martins; P Tozer; P Ranchod; R K S Phillips
Journal:  Tech Coloproctol       Date:  2011-03-23       Impact factor: 3.781

7.  Efficacy of Guggulu and Shallaki based Ksharasutra with Triphala Guggulu orally in the management of Bhagandara w.s.r. to fistula-in-ano: A open labelled randomized comparative clinical study.

Authors:  Aditya Nema; Sanjay Kumar Gupta; Tukaram Dudhamal; Vyasdeva Mahanta
Journal:  Ayu       Date:  2022-06-03

8.  Fistulas in ano: endoanal ultrasonographic assessment assists decision making for surgery.

Authors:  K I Deen; J G Williams; R Hutchinson; M R Keighley; D Kumar
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

9.  The role of transperineal ultrasonography in the assessment of the internal opening of cryptogenic anal fistula.

Authors:  H Kleinübing; J F Jannini; A C L Campos; M Pinho; L C Ferreira
Journal:  Tech Coloproctol       Date:  2007-12-03       Impact factor: 3.781

10.  MRI for assessment of anal fistula.

Authors:  Michael R Torkzad; Urban Karlbom
Journal:  Insights Imaging       Date:  2010-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.